Eaton Vance Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $145K | Buy |
|
|||||
|
2022
Q2 | $134K | Buy |
|
|||||
|
2022
Q1 | $127K | Buy |
|
|||||
|
2021
Q4 | $106K | Hold |
|
|||||
|
2021
Q3 | $88K | Sell |
|
|||||
|
2021
Q2 | $208K | Buy |
|
|||||
|
2021
Q1 | $207K | Sell |
|
|||||
|
2020
Q4 | $190K | Sell |
|
|||||
|
2020
Q3 | $372K | Sell |
|
|||||
|
2020
Q2 | $978K | Sell |
|
|||||
|
2020
Q1 | $4.54M | Sell |
|
|||||
|
2019
Q4 | $5.82M | Sell |
|
|||||
|
2019
Q3 | $4.13M | Sell |
|
|||||
|
2019
Q2 | $6.85M | Sell |
|
|||||
|
2019
Q1 | $12.5M | Sell |
|
|||||
|
2018
Q4 | $12.3M | Sell |
|
|||||
|
2018
Q3 | $36.4M | Sell |
|
|||||
|
2018
Q2 | $41.2M | Sell |
|
|||||
|
2018
Q1 | $57.9M | Buy |
|
|||||
|
2017
Q4 | $32.1M | Sell |
|
|||||
|
2017
Q3 | $30.9M | Sell |
|
|||||
|
2017
Q2 | $58.7M | Sell |
|
|||||
|
2017
Q1 | $65.3M | Buy |
|
|||||
|
2016
Q4 | $63.9M | Sell |
|
|||||
|
2016
Q3 | $215M | Sell |
|
|||||
|
2016
Q2 | $340M | Buy |
|
|||||
|
2016
Q1 | $282M | Sell |
|
|||||
|
2015
Q4 | $376M | Buy |
|
|||||
|
2015
Q3 | $264M | Sell |
|
|||||
|
2015
Q2 | $288M | Buy |
|
|||||
|
2015
Q1 | $266M | Buy |
|
|||||
|
2014
Q4 | $210M | Buy |
|
|||||
|
2014
Q3 | $96.9M | Sell |
|
|||||
|
2014
Q2 | $94.6M | Sell |
|
|||||
|
2014
Q1 | $95.9M | Sell |
|
|||||
|
2013
Q4 | $72.8M | Sell |
|
|||||
|
2013
Q3 | $69.9M | Sell |
|
|||||
|
2013
Q2 | $74.5M | Buy |
|